SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-002753
Filing Date
2012-03-15
Accepted
2012-03-15 16:02:50
Documents
14
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2208169z10-k.htm 10-K 1043926
2 EX-23.1 a2208169zex-23_1.htm EX-23.1 6147
3 EX-31.1 a2208169zex-31_1.htm EX-31.1 8226
4 EX-31.2 a2208169zex-31_2.htm EX-31.2 8240
5 EX-32.1 a2208169zex-32_1.htm EX-32.1 8614
12 G168461.JPG g168461.jpg GRAPHIC 144418
13 G96946.JPG g96946.jpg GRAPHIC 119958
14 G336364.JPG g336364.jpg GRAPHIC 51498
  Complete submission text file 0001047469-12-002753.txt   4388668

Data Files

Seq Description Document Type Size
6 EX-101.INS astx-20111231.xml EX-101.INS 524080
7 EX-101.SCH astx-20111231.xsd EX-101.SCH 20728
8 EX-101.CAL astx-20111231_cal.xml EX-101.CAL 55717
9 EX-101.DEF astx-20111231_def.xml EX-101.DEF 87716
10 EX-101.LAB astx-20111231_lab.xml EX-101.LAB 303715
11 EX-101.PRE astx-20111231_pre.xml EX-101.PRE 142731
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Filer) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27628 | Film No.: 12694029
SIC: 2834 Pharmaceutical Preparations